AZADYNE LTD

Active London

Research and experimental development on biotechnology

3 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
A

AZADYNE LTD

Research and experimental development on biotechnology

Founded 24 Dec 2018 Active London, United Kingdom 3 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

FREYAGEN LIMITED 24 Dec 2018 — 11 Jan 2019
Accounts Submitted 30 Jun 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 30 Jan 2026 Next due 6 Jan 2027 8 months remaining
Net assets £939K £592 2024 year on year
Total assets £988K £133K 2024 year on year
Total Liabilities £49K £133K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

101 New Cavendish Street 1st Floor South London W1W 6XH United Kingdom

Email

info@example.com

Website

www.example.com

Full company profile for AZADYNE LTD (11740078), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 24 Dec 2018. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2019–2024)

Cash in Bank

£537.31k

Increased by £64.49k (+14%)

Net Assets

£939.07k

Increased by £592.00 (+0%)

Total Liabilities

£48.55k

Decreased by £133.27k (-73%)

Turnover

N/A

Employees

3

Decreased by 3 (-50%)

Debt Ratio

5%

Decreased by 11 (-69%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (4)

Investor NameInvestor SinceParticipating Rounds
Investor 1Mar 2019Seed
Investor 2Mar 2019Seed
Investor 3Mar 2019Seed

Share Capital

Share Capital

Share allotments and capital structure

5 Allotments 9,550 Shares £1.33m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
23 Dec 20243,109£760k£244.6
23 Nov 2022711£174k£244.6
3 Dec 2019530£0£0
20 Feb 20194,210£400k£95
18 Jan 2019990£0£0

Officers

Officers

1 active 2 resigned
Status
Jason Edward RuttDirectorBritishEngland5424 Dec 2018Active

Shareholders

Shareholders (16)

24haymarket Nominees Limited
16.7%
5,268
Kent Life Science Fund
16.6%
5,218

Persons with Significant Control

Persons with Significant Control (1)

1 Active 3 Ceased

Jason Edward Rutt

British

Active
Notified 23 Dec 2019
Residence England
DOB September 1971
Nature of Control
  • Right To Appoint And Remove Directors

John Michael Southern

Ceased 20 Feb 2019

Ceased

Vincent Patrick Kelly

Ceased 20 Feb 2019

Ceased

Stephen Joseph Cannon

Ceased 20 Feb 2019

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
30 Jan 2026Confirmation StatementConfirmation statement made on 23 Dec 2025 with updates
30 Jun 2025AccountsAnnual accounts made up to 31 Dec 2024
28 Feb 2025Confirmation StatementConfirmation statement made on 23 Dec 2024 with updates
22 Jan 2025ResolutionResolutions
21 Jan 2025CapitalAllotment of shares (GBP 3,150.5) on 8 Jan 2025
30 Jan 2026 Confirmation Statement

Confirmation statement made on 23 Dec 2025 with updates

30 Jun 2025 Accounts

Annual accounts made up to 31 Dec 2024

28 Feb 2025 Confirmation Statement

Confirmation statement made on 23 Dec 2024 with updates

22 Jan 2025 Resolution

Resolutions

21 Jan 2025 Capital

Allotment of shares (GBP 3,150.5) on 8 Jan 2025

Recent Activity

Latest Activity

Confirmation statement made on 23 Dec 2025 with updates

3 months ago on 30 Jan 2026

Annual accounts made up to 31 Dec 2024

10 months ago on 30 Jun 2025

Confirmation statement made on 23 Dec 2024 with updates

1 years ago on 28 Feb 2025

Resolutions

1 years ago on 22 Jan 2025

Allotment of shares (GBP 3,150.5) on 8 Jan 2025

1 years ago on 21 Jan 2025